![]() Bruker Cellular Analysis Bruker Cellular Analysis (formerly known as Phenomex, Berkeley Lights) is a digital cell biology company focused on enabling the development of biotherapeutics and other cell-based products. | ![]() ImmusanT ImmusanT is a clinical development-stage biotechnology company focused on an innovative disease-modifying approach to induce immune tolerance in autoimmune diseases. | Human Stem Cells Institute Human Stem Cells Institute is a biomedical technologies and healthcare solutions provider. | Genclis Genclis is a biotechnology company focused on developing therapies for both human and animal health using Transcription Infidelity (TI). | ||
Founding Date | Founding Date 2013 | Founding Date 2011 | Founding Date 2010 | Founding Date 2003 | Founding Date 2004 |
Type | Type Public | Type Subsidiary | Type Private | Type Public | Type Private |
Tags | |||||
Locations | Locations Philadelphia, US HQ | Locations Emeryville, US HQ | Locations Cambridge, US HQ | Locations Moscow, RU HQ | Locations Vandœuvre-lès-Nancy, FR HQ |
Employees | Employees 36817% increase | Employees 1391% decrease | Employees 2 | Employees N/A | Employees 6 |
Financial | |||||
Revenue (est.) | Revenue (est.) $64.7m (FY, 2018) | Revenue (est.) $78.6m (FY, 2022) | Revenue (est.) N/A | Revenue (est.) ₽1.7b (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $24.8m (FY, 2022) | Cost of goods N/A | Cost of goods ₽330.8m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $53.8m (FY, 2022) | Gross profit N/A | Gross profit ₽1.4b (FY, 2025) | Gross profit N/A |
Net income | Net income ($78.8m) (FY, 2018) | Net income ($98m) (FY, 2022) | Net income N/A | Net income ₽107.7m (FY, 2025) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 122.8m | Total funding raised $ 124.7m | Total funding raised $ 72.8m | Total funding raised N/A | Total funding raised N/A |

Bruker Cellular Analysis (formerly known as Phenomex, Berkeley Lights) is a digital cell biology company focused on enabling the development of biotherapeutics and other cell-based products.
View company
ImmusanT is a clinical development-stage biotechnology company focused on an innovative disease-modifying approach to induce immune tolerance in autoimmune diseases.
View companyHuman Stem Cells Institute is a biomedical technologies and healthcare solutions provider.
View companyGenclis is a biotechnology company focused on developing therapies for both human and animal health using Transcription Infidelity (TI).
View company